Status:
COMPLETED
An mHealth Intervention to Improve Medication Adherence and Health Outcomes
Lead Sponsor:
Duke University
Collaborating Sponsors:
West China Hospital
Conditions:
Coronary Heart Disease
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Investigators evaluated the efficacy of a pilot-tested mHealth intervention to improving medication adherence and health outcomes among patients with coronary heart disease.
Detailed Description
This was a two-arm parallel randomized controlled trial, in which 116 and 114 participants were assigned to the experimental and control groups, respectively. The mHealth intervention in this study ha...
Eligibility Criteria
Inclusion
- (1) had a medical diagnosis of coronary heart disease;
- (2) aged 18 years or older;
- (3) had an antihypertensive medication regimen for 90 days or more from enrollment;
- (4) able to read messages through mobile phone;
- (5) had a mobile phone that could receive messages from WeChat and reminders from Message Express;
- (6) capable of giving his/her own consent; and
- (7) had an electronic blood pressure cuff to check blood pressures and heart rates.
Exclusion
- was enrolled in other research studies
Key Trial Info
Start Date :
May 20 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2018
Estimated Enrollment :
230 Patients enrolled
Trial Details
Trial ID
NCT04703439
Start Date
May 20 2018
End Date
December 31 2018
Last Update
April 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
West China Hospital
Chengdu, Sichuan, China, 610041